Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1635 1636 1637 1658 1699
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18197948 | OPTIMIZED SIRNA SCAFFOLDS | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18140908 | SELECTIVE RNA-MODULATING AGENTS | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18247157 | MARF/MFN MODULATORS AND USES THEREOF | Final Rejection | University of Massachusetts |
| 19455761 | CAS12 PROTEINS AND USES THEREOF | Final Rejection | ZHEJIANG SYNSORBIO GENE TECHNOLOGY CO., LTD. |
| 15734768 | Methods for Identifying Promoters for Protein Production in Yeast | Final Rejection | BASF SE |
| 16989119 | Large Gene Excision and Insertion | Final Rejection | President and Fellows of Harvard College |
| 16851360 | RNA-Guided Transcriptional Regulation | Final Rejection | President and Fellows of Harvard College |
| 14319530 | RNA-Guided Transcriptional Regulation | Final Rejection | President and Fellows of Harvard College |
| 17631240 | COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA | Final Rejection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 16625207 | Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17995571 | METHODS FOR TARGETED INTEGRATION | Non-Final OA | CYTIVA SWEDEN AB |
| 17040943 | METHOD FOR INCREASING THE EXPRESSION LEVEL OF A NUCLEIC ACID MOLECULE OF INTEREST IN A CELL | Non-Final OA | KWS SAAT SE & Co. KGaA |
| 18270165 | COMPOSITION FOR INHIBITING METASTASIS AND ENHANCING ANTICANCER DRUG SENSITIVITY | Non-Final OA | Korea Advanced Institute of Science and Technology |
| 18573350 | COMPOSITIONS AND METHODS FOR TREATING PGM1 DEFICIENCY | Non-Final OA | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 18693636 | MRNA REGULON THERAPY FOR THE TREATMENT OF HAPLOINSUFFICIENCY DISORDERS | Non-Final OA | The Johns Hopkins University |
| 18392854 | COMPOSITIONS COMPRISING A LECITHIN CHOLESTEROL ACYLTRANSFERASE VARIANT AND USES THEREOF | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18162236 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | Final Rejection | The Trustees of the University of Pennsylvania |
| 18041504 | COMPOSITIONS AND METHODS FOR ENGINEERING AND SELECTION OF CAR T CELLS WITH DESIRED PHENOTYPES | Non-Final OA | Yale University |
| 18003968 | METHOD FOR SUPPRESSING CANCER METASTASIS THROUGH ALTERATION OF ADHESION DEPENDENCE OF CANCER CELLS | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18658840 | YEAST STRAINS WITH SELECTED OR ALTERED MITOTYPES AND METHODS OF MAKING AND USING THE SAME | Final Rejection | Wisconsin Alumni Research Foundation |
| 18058419 | RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS | Final Rejection | Wisconsin Alumni Research Foundation |
| 18565849 | ASSAY FOR QUANTITATIVE ASSESSMENT OF MRNA CAPPING EFFICIENCY | Non-Final OA | TRANSLATE BIO, INC. |
| 17915043 | ACTIVITY-DEPENDENT GENE THERAPY FOR NEUROLOGICAL DISORDERS | Non-Final OA | UCL BUSINESS LTD. |
| 18386551 | CHROMOSOME NEIGHBORHOOD STRUCTURES AND METHODS RELATING THERETO | Non-Final OA | Whitehead Institute for Biomedical Research |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy